Elizabeth Burchard, MD
Obstetrics & Gynecology · Providence, RINPI 1174595680
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.3%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 62.1% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $2,270 and has fallen 68.7% since, to $711 in 2025.
Across 96 payments — averaging $47.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Astellas Pharma US Inc$386
- Exeltis, USA Inc.$317
- Bayer$143
- Pfizer$113
- Coopersurgical, Inc.$112
- plus $672 from 18 others
What the payments were for
- Speaking & faculty fees$2,50054%
- Food & beverage$2,08245%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $2,858 |
| Astellas Pharma US Inc | 16 | $386 |
| Exeltis, USA Inc. | 7 | $317 |
| Bayer | 7 | $143 |
| Pfizer | 6 | $113 |
| Coopersurgical, Inc. | 5 | $112 |
| Sage Therapeutics, LLC | 4 | $84 |
| Myovant Sciences Inc. | 5 | $76 |
| Mayne Pharma Commercial LLC | 3 | $63 |
| Hologic Sales And Service, LLC | 2 | $62 |
| Mylan Pharmaceuticals Inc. | 3 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $52 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
| Shield Therapeutics Inc | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| AMAG Pharmaceuticals, Inc. | 1 | $19 |
| BD | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Boston Scientific | 1 | $19 |
| Agile Therapeutics, Inc. | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Lupin Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Slynd$127
How this compares
$4,601 in reported general payments places this provider in the 85th percentile of 139 obstetrics & gynecology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 22 | $2,944 |
| YuvafemEstradiol | 18 | $2,887 |
| AvianeLevonorgestrel/Ethin.Estradiol | 13 | $276 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $215 |
| Nystatin | 15 | $187 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 20 | $174 |
| Triamcinolone Acetonide | 15 | $68 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Providence
- Warren HuberProvidence$50K
- Lisa BoyleProvidence$30K
- Renee EgerProvidence$24K
- Gary WhartonProvidence$22K
- Christine FoleyProvidence$21K
- Cara MathewsProvidence$21K
- Michael BeitleProvidence$9K
- Ogechukwu EzikeProvidence$7K
- Beata DizoglioProvidence$6K
- Michele GangeProvidence$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.